Anthony M. Manning

Director

Anthony M. Manning (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $231K of GLUE (10,000 sh × $23.11, as filed), executed Jun 29.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$411K

shares × price, as filed

Last traded

Jun 29

Filed Jun 30

Median ADV $21.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $411K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

GLUE

Monte Rosa Therapeutics, Inc. GLUE · 0 buys · 2 sells 2 filings

Recent filings

GLUESALE Monte Rosa Therapeutics, Inc. View filing → $231K
10,000 sh × $23.11
Exec Jun 29
Filed Jun 30 · 5:30 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $180K
10,000 sh × $18.01
Exec May 21
Filed May 22 · 5:30 PM ET